TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

9.10$ +0.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Oculis Holding AG (OCS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -62 million CHF. Tick rows to compare them in a chart.

All figures in millions of CHF.

Tick rows to compare them in a chart (up to 4)

Cash Flow OCS
Line item 2020 2021 2022 2023 2024 2025
-12 -14 -25 -54 -47 -62
0.2 0.2 0.3 0.3 0.4 0.5
0.3 0.3 0.8 3.6 9.8 16
3.1 5.3 – – – –
-0.5 -0.8 6.0 -13 14 -0.1
0.0 0.0 3.5 0.0 0.2 0.3
0.0 0.0 -3.5 -54 -18 -59
– – – 0.0 0.0 0.0
-0.1 -0.2 -0.2 -0.2 -0.3 -0.4
4.9 55 1.7 130 54 179
-7.2 41 -26 19 -11 57
-12 -14 -29 -54 -48 -63

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?